Various alphabetized medical records
Industries

Life Sciences Antitrust & Competition

CRA’s life sciences litigation support services are grounded in a comprehensive understanding of pharmaceutical, biotechnology, medical device, and diagnostic markets. For more than 30 years, our experts have consulted with major life science companies, law firms, and regulatory agencies around the globe. We provide clients with the industry and analytical expertise needed to solve our clients’ most complex issues.

Engagements

  • 01
    CRA experts testify in civil antitrust trial involving alleged tying of PICC lines and location devices
    On October 3, 2022, CRA experts testified on behalf of C.R. Bard in AngioDynamics, Inc. v. C.R. Bard, Inc. et al. in the Northern District of New York....
    View engagement
  • 02
    CRA experts advise on oncology, consumer health, and animal health transactions before FTC
    CRA experts advised counsel and presented before the FTC on transactions involving Novartis’ acquisition of cancer drugs from GlaxoSmithKline, GSK’s joint...
    View engagement
  • 03
    At risk generic entry and impact of formulary status
    In a Hatch-Waxman litigation, a first-to-file generic manufacturer asked CRA to assess changes in formulary status that would result from the at-risk entry and...
    View engagement

Subscribe to receive our latest Insights.

Subscribe